DIVA vaccination strategies for avian influenza virus

Avian Diseases

Volumn 56, Issue 4 SUPPL.1, 2012, Pages 836-844

  Suarez, David L ^a  

^a Southeast Poultry Research Laboratory   (United States)

Author keywords

Avian influenza; DIVA; highly pathogenic; marker vaccine; trade; vaccination

Indexed keywords

INFLUENZA VACCINE;

ANIMAL; ANIMAL WELFARE; AVIAN INFLUENZA; CONFERENCE PAPER; IMMUNOLOGY; INFECTION CONTROL; METHODOLOGY; POULTRY; VIROLOGY;

ANIMAL WELFARE; ANIMALS; COMMUNICABLE DISEASE CONTROL; INFLUENZA IN BIRDS; INFLUENZA VACCINES; POULTRY;

ANIMALIA; AVES; AVIAN INFLUENZA VIRUS;

EID: 84871951137     PISSN: 00052086     EISSN: None     Source Type: Journal    
DOI: 10.1637/10207-041512-Review.1     Document Type: Conference Paper

References (64)

1. Akey, B. L. Low-pathogenicity H7N2 avian influenza outbreak in Virginia during 2002. Avian Dis. 47:1099-1103. 2003. (Pubitemid 37143892)
2. Avellaneda, G., E. Mundt, C. W. Lee, S. Jadhao, and D. L. Suarez. Differentiation of infected and vaccinated animals (DIVA) using the NS1 protein of avian influenza virus. Avian Dis. 54:278-286. 2010.
3. Avellaneda, G., M. J. Sylte, C. W. Lee, and D. L. Suarez. A heterologous neuraminidase subtype strategy for the differentiation of infected and vaccinated animals (DIVA) for avian influenza virus using an alternative neuraminidase inhibition test. Avian Dis. 54:272-277. 2010.
4. Beard, C. W. To vaccinate or not to vaccinate. In: Second International Symposium on Avian Influenza. Extension Duplicating Services University of Wisconsin-Madison, Athens, GA. pp. 258-263. 1986.
5. Beato, M. S., M. Rigoni, A. Milani, and I. Capua. Generation of avian influenza reassortant viruses of the H7N5 subtype as potential vaccine candidates to be used in the framework of a "DIVA" vaccination strategy. Avian Dis. 51:479-480. 2007. (Pubitemid 46671337)
6. Birch-Machin, I., A. Rowan, J. Pick, J. Mumford, and M. Binns. Expression of the nonstructural protein NS1 of equine influenza A virus: detection of anti-NS1 antibody in post infection equine sera. J. Virol. Methods. 65:255-263. 1997. (Pubitemid 27240507)
7. Blancou, J. History of the surveillance and control of transmissible animal diseases. World Organisation for Animal Health, Office of International Des Epizooties, Paris, France. 2003.
8. Bouma, A., I. Claassen, K. Natih, D. Klinkenberg, C. A. Donnelly, G. Koch, and M. van Boven. Estimation of transmission parameters of H5N1 avian influenza virus in chickens. PLoS Pathog 5:e1000281. 2009.
9. Capua, I., G. Cattoli, and S. Marangon. DIVA-a vaccination strategy enabling the detection of field exposure to avian influenza. Dev. Biol. (Basel) 119:229-233. 2004. (Pubitemid 41717461)
10. Capua, I., C. Terregino, G. Cattoli, F. Mutinelli, and J. F. Rodriguez. Development of a DIVA (differentiating infected from vaccinated animals) strategy using a vaccine containing a heterologous neuraminidase for the control of avian influenza. Avian Pathol. 32:47-55. 2003. (Pubitemid 36137470)
11. Capua, I., C. Terregino, G. Cattoli, and A. Toffan. Increased resistance of vaccinated turkeys to experimental infection with an H7N3 low-pathogenicity avian influenza virus. Avian Pathol. 33:158-163. 2004. (Pubitemid 38517170)
12. Cattoli, G., A. Milani, F. Bettini, M. Serena Beato, M. Mancin, C. Terregino, and I. Capua. Development and validation of an anti-N3 indirect immunofluorescent antibody test to be used as a companion diagnostic test in the framework of a "DIVA" vaccination strategy for avian influenza infections in poultry. Avian Pathol. 35:154-159. 2006.
13. Davies, G. The foot and mouth disease (FMD) epidemic in the United Kingdom 2001. Comp. Immunol. Microbiol. Infect. Dis. 25:331-343. 2002. (Pubitemid 35023446)
14. Dundon, W. G., S. Maniero, A. Toffan, I. Capua, and G. Cattoli. Appearance of serum antibodies against the avian influenza nonstructural 1 protein in experimentally infected chickens and turkeys. Avian Dis. 51:209-212. 2007. (Pubitemid 46671281)
15. Elvinger, F., B. L. Akey, D. A. Senne, F. W. Pierson, B. A. Porter-Spalding, E. Spackman, and D. L. Suarez. Characteristics of diagnostic tests used in the 2002 low-pathogenicity avian influenza H7N2 outbreak in Virginia. J. Vet. Diagn. Invest. 19:341-348. 2007. (Pubitemid 351202210)
16. Halvorson, D. A. Control of Low Pathogenicity Avian Influenza. In: Avian Influenza. D. E. Swayne, ed. Blackwell Publishing, Ames, IA. pp. 513-536. 2008.
17. Ho, H. T., H. L. Qian, F. He, T. Meng, M. Szyporta, N. Prabhu, M. Prabakaran, K. P. Chan, and J. Kwang. Rapid detection of H5N1 subtype influenza viruses by antigen capture enzyme-linked immunosorbent assay using H5-and N1-specific monoclonal antibodies. Clin. Vaccine Immunol. 16:726-732. 2009.
18. Hoffmann, E., A. S. Lipatov, R. J. Webby, E. A. Govorkova, and R. G. Webster. Role of specific hemagglutinin amino acids in the immunogenicity and protection of H5N1 influenza virus vaccines. Proc. Natl. Acad. Sci. U. S. A. 102:12915-12920. 2005. (Pubitemid 41279464)
19. Jadhao, S. J., C. W. Lee, M. Sylte, and D. L. Suarez. Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens. Vaccine 27:6247-6260. 2009.
20. James, C. M., Y. Y. Foong, J. P. Mansfield, S. G. Fenwick, and T. M. Ellis. Use of tetanus toxoid as a differentiating infected from vaccinated animals (DIVA) strategy for sero-surveillance of avian influenza virus vaccination in poultry. Vaccine 25:5892-5901. 2007. (Pubitemid 47043219)
21. James, C. M., Y. Y. Foong, J. P. Mansfield, A. R. Vind, S. G. Fenwick, and T. M. Ellis. Evaluation of a positive marker of avian influenza vaccination in ducks for use in H5N1 surveillance. Vaccine 26:5345-5351. 2008.
22. James-Berry, C. M., D. Middleton, J. P. Mansfield, S. G. Fenwick, and T. M. Ellis. Use of a tetanus toxoid marker to allow differentiation of infected from vaccinated poultry without affecting the efficacy of a H5N1 avian influenza virus vaccine. Vet. Rec. 167:695-699. 2010.
23. Kim, J. N., S. H. Byun, S. Y. Kang, and I. P. Mo. Evaluation of neuraminidase antigen-based competitive enzyme-linked immunosorbent assay in chickens vaccinated with avian influenza inactivated vaccine. Avian Dis. 54:682-685. 2010.
24. Kim, M. C., J. G. Choi, J. S. Kwon, H. M. Kang, M. R. Paek, O. M. Jeong, J. H. Kwon, and Y. J. Lee. Field application of the H9M2e enzymelinked immunosorbent assay for differentiation of H9N2 avian influenza virus-infected chickens from vaccinated chickens. Clin. Vaccine Immunol. 17:1977-1984. 2010.
25. Kwon, J. S., M. C. Kim, O. M. Jeong, H. M. Kang, C. S. Song, J. H. Kwon, and Y. J. Lee. Novel use of a N2-specific enzyme-linked immunosorbent assay for differentiation of infected from vaccinated animals (DIVA)-based identification of avian influenza. Vaccine 27:3189-3194. 2009.
26. Lambrecht, B., M. Steensels, S. Van Borm, G. Meulemans, and T. van den Berg. Development of an M2e-specific enzyme-linked immunosorbent assay for differentiating infected from vaccinated animals. Avian Dis. 51:221-226. 2007. (Pubitemid 46671283)
27. Lee, C. W., D. A. Senne, and D. L. Suarez. Effect of vaccine use in the evolution of Mexican lineage H5N2 avian influenza virus. J Virol. 78:8372-8381. 2004. (Pubitemid 38944321)
28. Lee, C. W., D. A. Senne, and D. L. Suarez. Generation of reassortant influenza vaccines by reverse genetics that allows utilization of a DIVA (differentiating infected from vaccinated animals) strategy for the control of avian influenza. Vaccine 22:3175-3181. 2004. (Pubitemid 39037222)
29. Lee, C. W., D. A. Senne, and D. L. Suarez. Development and application of reference antisera against 15 hemagglutinin subtypes of influenza virus by DNA vaccination of chickens. Clin. Vaccine Immunol. 13:395-402. 2006.
30. Lee, C. W., and D. L. Suarez. Avian influenza virus: prospects for prevention and control by vaccination. Anim. Health Res. Rev. 6:1-15. 2005.
31. Lee, Y. J., H. W. Sung, J. G. Choi, E. K. Lee, O. M. Jeong, Y. K. Kwon, J. H. Kwon, C. S. Song, and J. H. Kimd. Effects of homologous and heterologous neuraminidase vaccines in chickens against H5N1 highly pathogenic avian influenza. Avian Dis. 51:476-478. 2007. (Pubitemid 46671336)
32. Liu, Y., E. Mundt, A. Mundt, M. Sylte, D. L. Suarez, D. E. Swayne, and M. Garcia. Development and evaluation of an avian influenza, neuraminidase subtype 1, indirect enzyme-linked immunosorbent assay for poultry using the differentiation of infected from vaccinated animals control strategy. Avian Dis. 54:613-621. 2010.
33. Lozano-Dubernard, B., E. Soto-Priante, D. Sarfati-Mizrahi, F. Castro-Peralta, R. Flores-Castro, E. Loza-Rubio, and M. Gay-Gutierrez. Protection and differentiation of infected from vaccinated animals by an inactivated recombinant Newcastle disease virus/avian influenza H5 vaccine. Avian Dis. 54:242-245. 2010.
34. Marangon, S., I. Capua, G. Pozza, and U. Santucci. Field experiences in the control of avian influenza outbreaks in densely populated poultry areas. Dev. Biol. (Basel) 119:155-164. 2004. (Pubitemid 41717454)
35. Marche, S., B. Lambrecht, and T. van den Berg. Evaluation of different serologic markers for the early detection of avian influenza infection in chickens. Avian Dis. 54:690-698. 2010.
36. Moreno, A., E. Brocchi, D. Lelli, D. Gamba, M. Tranquillo, and P. Cordioli. Monoclonal antibody based ELISA tests to detect antibodies against neuraminidase subtypes 1, 2 and 3 of avian influenza viruses in avian sera. Vaccine 27:4967-4974. 2009.
37. Morton, D. B. Vaccines and animal welfare. Rev. Sci. Tech. 26:157-163. 2007. (Pubitemid 47148819)
38. Ozaki, H., T. Sugiura, S. Sugita, H. Imagawa, and H. Kida. Detection of antibodies to the nonstructural protein (NS1) of influenza A virus allows distinction between vaccinated and infected horses. Vet. Microbiol. 82:111-119. 2001. (Pubitemid 32566190)
39. Pasick, J. Application of DIVA vaccines and their companion diagnostic tests to foreign animal disease eradication. Anim. Health Res. Rev. 5:257-262. 2004.
40. Perez-Ramirez, E., V. Rodriguez, D. Sommer, J. M. Blanco, P. Acevedo, U. Heffels-Redmann, and U. Hofle. Serologic testing for avian influenza viruses in wild birds: comparison of two commercial competition enzyme-linked immunosorbent assays. Avian Dis. 54:729-733. 2010.
41. Poetri, O. N., A. Bouma, S. Murtini, I. Claassen, G. Koch, R. D. Soejoedono, J. A. Stegeman, and M. van Boven. An inactivated H5N2 vaccine reduces transmission of highly pathogenic H5N1 avian influenza virus among native chickens. Vaccine 27:2864-2869. 2009.
42. Suarez, D. L. Overview of avian influenza DIVA test strategies. Biologicals 33:221-226. 2005. (Pubitemid 41743811)
43. Suarez, D. L. Avian influenza: our current understanding. Anim. Health. Res. Rev. 11:19-33. 2010.
44. Suarez, D. L., C. W. Lee, and D. E. Swayne. Avian influenza vaccination in North America: strategies and difficulties. Dev. Biol. (Basel) 124:117-124. 2006. (Pubitemid 43258907)
45. Suarez, D. L., and S. Schultz-Cherry. Immunology of avian influenza virus: a review. Dev. Comp. Immunol. 24:269-283. 2000. (Pubitemid 30136306)
46. Swayne, D. E., G. Avellaneda, T. R. Mickle, N. Pritchard, J. Cruz, and M. Bublot. Improvements to the hemagglutination inhibition test for serological assessment of recombinant fowlpox-H5-avian-influenza vaccination in chickens and its use along with an agar gel immunodiffusion test for differentiating infected from noninfected vaccinated animals. Avian Dis. 51:697-704. 2007. (Pubitemid 47480266)
47. Swayne, D. E., M. Garcia, J. R. Beck, N. Kinney, and D. L. Suarez. Protection against diverse highly pathogenic H5 avian influenza viruses in chickens immunized with a recombinant fowlpox vaccine containing an H5 avian influenza hemagglutinin gene insert. Vaccine 18:1088-1095. 2000.
48. Swayne, D. E., G. Pavade, K. Hamilton, B. Vallat, and K. Miyagishima. Assessment of national strategies for control of highpathogenicity avian influenza and low-pathogenicity notifiable avian influenza in poultry, with emphasis on vaccines and vaccination. Rev. Sci. Tech. 30:839-870. 2011.
49. Sylte, M. J., B. Hubby, and D. L. Suarez. Influenza neuraminidase antibodies provide partial protection for chickens against high pathogenic avian influenza infection. Vaccine 25:3763-3772. 2007. (Pubitemid 46591937)
50. Thrusfield, M., L. Mansley, P. Dunlop, A. Pawson, and J. Taylor. The foot-and-mouth disease epidemic in Dumfries and Galloway, 2001. 2: serosurveillance, and efficiency and effectiveness of control procedures after the national ban on animal movements. Vet. Rec. 156:269-278. 2005. (Pubitemid 40352978)
51. Tumpey, T. M., R. Alvarez, D. E. Swayne, and D. L. Suarez. Diagnostic approach for differentiating infected from vaccinated poultry on the basis of antibodies to NS1, the nonstructural protein of influenza A virus. J. Clin. Microbiol. 43:676-683. 2005. (Pubitemid 40256018)
52. Upadhyay, C., A. Ammayappan, and V. N. Vakharia. Detection of NP, N3 and N7 antibodies to avian influenza virus by indirect ELISA using yeast-expressed antigens. Virol. J. 6:158. 2009.
53. Vannie, P., I. Capua, M. F. Le Potier, D. K. Mackay, B. Muylkens, S. Parida, D. J. Paton, and E. Thiry. Marker vaccines and the impact of their use on diagnosis and prophylactic measures. Rev. Sci. Tech. 26:351-372. 2007. (Pubitemid 47346049)
54. van Oirschot, J. T. Diva vaccines that reduce virus transmission. J. Biotechnol. 73:195-205. 1999. (Pubitemid 29376450)
55. van Oirschot, J. T. Vaccinology of classical swine fever: from lab to field. Vet. Microbiol. 96:367-384. 2003. (Pubitemid 37346277)
56. Veits, J., D. Wiesner, W. Fuchs, B. Hoffmann, H. Granzow, E. Starick, E. Mundt, H. Schirrmeier, T. Mebatsion, T. C. Mettenleiter, and A. Romer-Oberdorfer. Newcastle disease virus expressing H5 hemagglutinin gene protects chickens against Newcastle disease and avian influenza. Proc. Natl. Acad. Sci. U. S. A. 103:8197-8202. 2006. (Pubitemid 43801075)
57. Wang, L., Z. Qin, M. Pantin-Jackwood, O. Faulkner, D. L. Suarez, M. Garcia, B. Lupiani, S. M. Reddy, Y. M. Saif, and C. W. Lee. Development of DIVA (differentiation of infected from vaccinated animals) vaccines utilizing heterologous NA and NS1 protein strategies for the control of triple reassortant H3N2 influenza in turkeys. Vaccine 29:7966-7974. 2011.
58. Wang, W., B. Lu, H. Zhou, A. L. Suguitan Jr, X. Cheng, K. Subbarao, G. Kemble, and H. Jin. Glycosylation at 158N of the hemagglutinin protein and receptor binding specificity synergistically affect the antigenicity and immunogenicity of a live attenuated H5N1 A/Vietnam/1203/2004 vaccine virus in ferrets. J. Virol. 84:6570-6577. 2010.
59. Watson, D. S., S. M. Reddy, V. Brahmakshatriya, and B. Lupiani. A multiplexed immunoassay for detection of antibodies against avian influenza virus. J. Immunol. Methods 340:123-131. 2009.
60. Webster,R.G., W. G. Laver, and E.D.Kilbourne.Reactions of antibodies with surface antigens of influenza virus. J. Gen. Virol. 3:315-326. 1968.
61. Whiting, T. L. Foreign animal disease outbreaks, the animal welfare implications for Canada: risks apparent from international experience. Can. Vet. J. 44:805-815. 2003. (Pubitemid 37406839)
62. World Organisation for Animal Health. Avian influenza. In: Terrestrial Animal Health Code-2011. World Organisation for Animal Health (Office International Epizooties), Paris, France. 2011.
63. Wu, R., Q. Chen, L. Zheng, J. Chen, Z. Sui, Y. Guan, and Z. Chen. Generation and evaluation of an H9N1 influenza vaccine derived by reverse genetics that allows utilization of a DIVA strategy for control of H9N2 avian influenza. Arch. Virol. 154:1203-1210. 2009.
64. Zhao, S., M. Jin, H. Li, Y. Tan, G. Wang, R. Zhang, and H. Chen. Detection of antibodies to the nonstructural protein (NS1) of avian influenza viruses allows distinction between vaccinated and infected chickens. Avian Dis. 49:488-493. 2005. (Pubitemid 41833175)